ArticleScientific reports2023

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.

Martin Sterba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.